Showing results (41-50 of 316) with videos related to
Sort By:
Pageof 32
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 20, 2004
Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United StatesChagriya Kitiyakara, Paul Eggers, Jeffrey B KoppAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 16, 2018
Genetic Testing in Clinical SettingsNora Franceschini, Amber Frick, Jeffrey B KoppNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 8, 2011
TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytesToru Sakairi, Yoshifusa Abe, Jeffrey B KoppSeminars in Nephrology|November 8, 2017
APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated NephropathyJeffrey B Kopp, Jurgen Heymann, Cheryl A WinklerClinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseasesLaura Barisoni, H William Schnaper, Jeffrey B KoppDiscovery Medicine|September 1, 2015
New horizons for human pathogenic autoantibodiesPeter D Burbelo, Jason Keller, Jeffrey B KoppSeminars in Nephrology|October 30, 2021
Podocytopathy in Obesity: Challenges of Living LargeGabriel Giannini, Jeffrey B Kopp, Avi Z RosenbergAnnals of Internal Medicine|August 6, 2003
Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigationsPaul L Kimmel, Laura Barisoni, Jeffrey B KoppArchives of Pathology & Laboratory Medicine|February 7, 2009
Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapyLaura Barisoni, H William Schnaper, Jeffrey B KoppFrontiers in Pharmacology|September 14, 2020
COVID-19 Usurps Host Regulatory NetworksColleen S Curran, Donna R Rivera, Jeffrey B KoppPageof 32